Tribute Pharmaceuticals Canada

Tribute Pharmaceuticals Canada is a Canadian specialty company founded in 1981, dedicated to advancing healthcare in Canada with proven pharmaceuticals and a commitment to patient and physician trust. The company operates in the Biotechnology and Health Care industries, with a focus on the acquisition, licensing, development, and management of pharmaceutical and healthcare products, primarily targeting the Canadian market. Tribute Pharmaceuticals prides itself on the expertise of its employees, sales representatives, and authorized third-party providers. The company is devoted to delivering high-quality healthcare products addressing well-recognized medical conditions and diseases, while complying with regulatory standards in Canada and globally. The last investment in Tribute Pharmaceuticals was a $4.10M Post-IPO Equity investment at 03 June 2015. With facilities in Milton and London, Ontario, Tribute Pharmaceuticals has positioned itself as a trusted player in the Canadian pharmaceutical market, offering patients and physicians clinically proven pharmaceutical products. As the company continues to uphold its mission to advance healthcare, it presents an intriguing investment opportunity in the Canadian healthcare sector.